[1] Kondrup J, Rasmussen H, Hamberg O, et al. Nutritional risk screening (NRS 2002):a new method based on an analysis of controlled clinical trials [J]. Clin Nutr, 2003,22(3):321-336.
[3] Pradelli L, Iannazzo S, Zaniolo O, et al. Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: a discrete event simulation model based on Italian data [J]. Int J Technol Assess Health Care, 2012, 28(1): 22-28.
[5] Rodas P C, Rooyackers O, Hebert C, et al. Glutamine and glutathione at ICU admission in relation to outcome[J]. Clin Sci, 2012, 122(12):591-597.
[6] Genton L, Pichard C. Protein catabolism and requirements in severe illness[J]. Int J Vitam Nutr Res, 2011, 81(2-3):143-152.
[7] 吴肇汉.规范营养治疗支持[J].中华肝胆外科杂志,2007,13(1):2-3.
[8] Hegazi RA, Wischmeyer PE. Clinical review: optimizing enteral nutrition for critically ill patients--a simple data-driven formula[J]. Crit Care, 2011,15(6):234-235.
[9] Wasiak J, Cleland H, Jeffery R. Early versus late enteral nutritional support in adults with burn injury: a systematic review[J]. J Hum Nutr Diet, 2007,20(2):75-83.
[10] Cahill N E, Murch L, Jeejeebhoy K, et al. When early enteral feeding is not possible in critically ill patients: results of a multicenter observational study[J]. JPEN, 2011, 35(2):160-168.
[11] McClave S A, Chang W K,Dhaliwal R, et al. Nutrition support in acute pancreatitis: a systematic review of the literature[J]. JPEN,2006,30(2): 143-156.
[12] Kreymann K G,Berger M M,Deutz N P, et al. ESPEN Guidelines on enteral nutrition intensive care[J]. Clin Nutr,2006,25:210-223.
[13] Simpson F, Doig G S. Parenteral V S. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle[J]. Intensive Care Med, 2005,31(1):12-23.
[14] Barr J, Hecht M, Flavin K E, et al. Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol[J].Chest, 2004,125:1446-1457
[15] 蔡东联.实用营养师手册[M].北京:人民卫生出版社,2009:316-385.
[16] Westergren A, Hedin G. Do study circles and a nutritional care policy improve nutritional care in a short- and long-term perspective in special accommodations[J]. Food Nutr Res,2010,24:54.
[17] Peter J V, Moran J L, Phillips-Hughes J. A meta analysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients[J]. Crit Care Med, 2005,33(1):213-220.
[18] Oz H S, Chen T S, Neuman M. Nutrition intervention: a strategy against systemic inflammatory syndrome[J]. JPEN, 2009,33(4):380-389.
[19] Kreymann K G. Early nutrition support in critical care: a European perspective[J]. Curr Opin Clin Nutr Metab Care,2008,11(2):156-159.
[20] Louie B E,Noseworthy T,Halley D.2004 Maclean—Mueller prize enteral or parenterat nutrition for severe pancreatitis:A randomitd controlledtrialand health technology assessment[J].Can J Surg,2005,48(4):298-306.
[21] Cahill N E, Dhaliwal R, Day A G, et al. Nutrition therapy in the critical care setting: what is "best achievable" practice? An international multicenter observational study[J]. Crit Care Med, 2010,38(2):395-401.
[22] Stout S M, Cober M P. Metabolic effects of cyclic parenteral nutrition infusion in adults and children[J]. Nutr Clin Pract, 2010,25(3):277-281.
[23] Dhaliwal R,Jurewitsch B,Harrietha D,et al. Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence[J]. Intensive Care Med, 2004,30:1666-1671.
[24] MacLeod J B, Lefton J, Houghton D, et al. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients[J].J Trauma, 2007,63(1):57-61.
[26] Singh N, Gupta D, Aggarwal A N, et al. An assessment of nutritional support to critically ill patients and its correlation with outcomes in a respiratory intensive care unit[J]. Respir Care, 2009, 54(12):1688-1696.
[27] Cangelosi M J, Auerbach H R, Cohen J T. A clinical and economic evaluation of enteral nutrition[J]. Curr Med Res Opin, 2011, 27(2): 413-422.
[28] Odile M, Denis B, Fabienne, et al. Effect of an enteral diet supplemented with a specific blend of amino acid on plasma and muscle protein synthesis in ICU patients[J]. Clinical Nutrition, 2007, 26(1):30-40.
[29] Déchelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study[J]. Crit Care Med,2006,34(3):598-604.
[30] Novak F, Heyland D K, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence[J]. Crit Care Med, 2002,30(9): 2022-2029.
[31] Zhou Y, Wu X T, Yang G, et al. Clinical evidence of growth hormone for patients undergoing abdominal surgery: metal-analysis of randomized controlled trials[J]. World J Gastroenterol, 2005,11(25):3925-3930.
[32] Taylor B E, Buchman T G. Is there a role for growth hormone therapy in refractory critical illness[J]. Curr Opin Crit Care,2008,14(4):438-444.
[33] Heller A R, Rssler S, Litz R J. Omega-3 fatty acids improve the diagnosis-related clinical outcome[J]. Crit Care Med,2006,34(4):972-979.